BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 30696455)

  • 1. Early dysregulation of cardiac-specific microRNA-208a is linked to maladaptive cardiac remodelling in diabetic myocardium.
    Rawal S; Nagesh PT; Coffey S; Van Hout I; Galvin IF; Bunton RW; Davis P; Williams MJA; Katare R
    Cardiovasc Diabetol; 2019 Jan; 18(1):13. PubMed ID: 30696455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of miR-15a/b accelerates fibrotic remodelling in the Type 2 diabetic human and mouse heart.
    Rawal S; Munasinghe PE; Nagesh PT; Lew JKS; Jones GT; Williams MJA; Davis P; Bunton D; Galvin IF; Manning P; Lamberts RR; Katare R
    Clin Sci (Lond); 2017 May; 131(9):847-863. PubMed ID: 28289072
    [No Abstract]   [Full Text] [Related]  

  • 3. Secretory products from epicardial adipose tissue from patients with type 2 diabetes impair mitochondrial β-oxidation in cardiomyocytes via activation of the cardiac renin-angiotensin system and induction of miR-208a.
    Blumensatt M; Fahlbusch P; Hilgers R; Bekaert M; Herzfeld de Wiza D; Akhyari P; Ruige JB; Ouwens DM
    Basic Res Cardiol; 2017 Jan; 112(1):2. PubMed ID: 27864612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-27a regulates beta cardiac myosin heavy chain gene expression by targeting thyroid hormone receptor beta1 in neonatal rat ventricular myocytes.
    Nishi H; Ono K; Horie T; Nagao K; Kinoshita M; Kuwabara Y; Watanabe S; Takaya T; Tamaki Y; Takanabe-Mori R; Wada H; Hasegawa K; Iwanaga Y; Kawamura T; Kita T; Kimura T
    Mol Cell Biol; 2011 Feb; 31(4):744-55. PubMed ID: 21149577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of microRNA-532 enhances cardiomyocyte apoptosis in the diabetic heart.
    Chandrasekera DNK; Neale JPH; van Hout I; Rawal S; Coffey S; Jones GT; Bunton R; Sugunesegran R; Parry D; Davis P; Manning P; Williams MJA; Katare R
    Apoptosis; 2020 Jun; 25(5-6):388-399. PubMed ID: 32418060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Foxo1 by insulin resistance promotes cardiac dysfunction and β-myosin heavy chain gene expression.
    Qi Y; Zhu Q; Zhang K; Thomas C; Wu Y; Kumar R; Baker KM; Xu Z; Chen S; Guo S
    Circ Heart Fail; 2015 Jan; 8(1):198-208. PubMed ID: 25477432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiRNA-208a and miRNA-208b are triggered in thyroid hormone-induced cardiac hypertrophy - role of type 1 Angiotensin II receptor (AT1R) on miRNA-208a/α-MHC modulation.
    Diniz GP; Takano AP; Barreto-Chaves ML
    Mol Cell Endocrinol; 2013 Jul; 374(1-2):117-24. PubMed ID: 23623871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BMP-7 attenuates left ventricular remodelling under pressure overload and facilitates reverse remodelling and functional recovery.
    Merino D; Villar AV; García R; Tramullas M; Ruiz L; Ribas C; Cabezudo S; Nistal JF; Hurlé MA
    Cardiovasc Res; 2016 Jun; 110(3):331-45. PubMed ID: 27068510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Sodium-Glucose Linked Transporter 2 Inhibition With Ertugliflozin on Mitochondrial Function, Energetics, and Metabolic Gene Expression in the Presence and Absence of Diabetes Mellitus in Mice.
    Croteau D; Luptak I; Chambers JM; Hobai I; Panagia M; Pimentel DR; Siwik DA; Qin F; Colucci WS
    J Am Heart Assoc; 2021 Jul; 10(13):e019995. PubMed ID: 34169737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-208a Increases Myocardial Endoglin Expression and Myocardial Fibrosis in Acute Myocardial Infarction.
    Shyu KG; Wang BW; Cheng WP; Lo HM
    Can J Cardiol; 2015 May; 31(5):679-90. PubMed ID: 25936493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise Regulates MicroRNAs to Preserve Coronary and Cardiac Function in the Diabetic Heart.
    Lew JK; Pearson JT; Saw E; Tsuchimochi H; Wei M; Ghosh N; Du CK; Zhan DY; Jin M; Umetani K; Shirai M; Katare R; Schwenke DO
    Circ Res; 2020 Nov; 127(11):1384-1400. PubMed ID: 32907486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart.
    Prakoso D; Lim SY; Erickson JR; Wallace RS; Lees JG; Tate M; Kiriazis H; Donner DG; Henstridge DC; Davey JR; Qian H; Deo M; Parry LJ; Davidoff AJ; Gregorevic P; Chatham JC; De Blasio MJ; Ritchie RH
    Cardiovasc Res; 2022 Jan; 118(1):212-225. PubMed ID: 33576380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice.
    Callis TE; Pandya K; Seok HY; Tang RH; Tatsuguchi M; Huang ZP; Chen JF; Deng Z; Gunn B; Shumate J; Willis MS; Selzman CH; Wang DZ
    J Clin Invest; 2009 Sep; 119(9):2772-86. PubMed ID: 19726871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the cardiac non-neuronal cholinergic system prevents the development of diabetes-associated cardiovascular complications.
    Saw EL; Pearson JT; Schwenke DO; Munasinghe PE; Tsuchimochi H; Rawal S; Coffey S; Davis P; Bunton R; Van Hout I; Kai Y; Williams MJA; Kakinuma Y; Fronius M; Katare R
    Cardiovasc Diabetol; 2021 Feb; 20(1):50. PubMed ID: 33618724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of microRNA-1 impairs cardiac contractile function by damaging sarcomere assembly.
    Ai J; Zhang R; Gao X; Niu HF; Wang N; Xu Y; Li Y; Ma N; Sun LH; Pan ZW; Li WM; Yang BF
    Cardiovasc Res; 2012 Aug; 95(3):385-93. PubMed ID: 22719074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin.
    Dai B; Li H; Fan J; Zhao Y; Yin Z; Nie X; Wang DW; Chen C
    Cardiovasc Diabetol; 2018 Sep; 17(1):123. PubMed ID: 30180843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial gene expression of microRNA-133a and myosin heavy and light chains, in conjunction with clinical parameters, predict regression of left ventricular hypertrophy after valve replacement in patients with aortic stenosis.
    Villar AV; Merino D; Wenner M; Llano M; Cobo M; Montalvo C; García R; Martín-Durán R; Hurlé JM; Hurlé MA; Nistal JF
    Heart; 2011 Jul; 97(14):1132-7. PubMed ID: 21586423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
    Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX
    Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure.
    Montgomery RL; Hullinger TG; Semus HM; Dickinson BA; Seto AG; Lynch JM; Stack C; Latimer PA; Olson EN; van Rooij E
    Circulation; 2011 Oct; 124(14):1537-47. PubMed ID: 21900086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA HIF1A-AS1 contributes to ventricular remodeling after myocardial ischemia/reperfusion injury by adsorption of microRNA-204 to regulating SOCS2 expression.
    Xue X; Luo L
    Cell Cycle; 2019 Oct; 18(19):2465-2480. PubMed ID: 31354024
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.